Human Insulin Market Share, Size, Trends, & Industry Analysis Report (2023-2030) | |
The Global Human Insulin Market size was reasonably estimated to be approximately USD 43000 Million in 2023 and is poised to generate revenue over USD 79100 Million by the end of 2030, projecting a CAGR of around 7.90% from 2023 to 2030. Human insulin is a hormone that closely resembles the insulin naturally produced in the human body. It plays a vital role in regulating the levels of glucose (sugar) in the blood. In individuals with diabetes, either the pancreas does not produce enough insulin (Type 1 diabetes) or the body cannot effectively use the insulin it produces (Type 2 diabetes). As a result, people with diabetes require insulin therapy to manage their blood sugar levels.To fulfil the need for insulin, the production of human insulin relies on a technique known as recombinant DNA technology. This method involves the insertion of the insulin-producing gene into host organisms, such as bacteria or yeast. These organisms are then capable of producing large quantities of human insulin. Subsequently, the insulin is purified and processed into various formulations, including short-acting, intermediate-acting, and long-acting insulin variants. To Learn More About This Report, Request A Free Sample Copy: https://pristineintelligence.com/request-sample/human-insulin-market-24 Top Key Players Covered in the Human Insulin Market: Novo Nordisk (Denmark), Eli Lilly and Company (US), Sanofi (France), Merck & Co. Inc. (US), Pfizer Inc. (US), Biocon Limited (India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), Gan & Lee Pharmaceuticals (China), Julphar (UAE), Bristol-Myers Squibb (US), Takeda Pharmaceutical Company Limited (Japan), Biodel Inc. (US), Oramed Pharmaceuticals Inc. (US) | |
Related Link: Click here to visit item owner's website (0 hit) | |
Target Prov.: All Provinces Target City : usa Last Update : Feb 15, 2024 7:09 AM Number of Views: 86 | Item Owner : akshay patil Contact Email: Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |